It’s important to always keep an eye out for the next big thing in the crypto market, and two tokens are causing quite the stir fighting for dominance – Conflux (CFX) and Zilliqa (ZIL). Both tokens present some innovative offerings to the market hence why they are battling it out, but meanwhile, TMS Network (TMSN) is soaring above them both without competition!
So, what exactly is TMS Network (TMSN) doing that is allowing it to soar over the likes of Conflux (CFX) and Zilliqa (ZIL)? Good question – continue reading to find out the answer!
TMS Network (TMSN)
TMS Network (TMSN) is an investment platform with a twist – you can trade both crypto and derivatives on it! TMS Network (TMSN) provides all the analytic tools, AI trade bots, social trading communities, and educational resources necessary to trade crypto, FX, CFDs, and equities within the same platform. This is an impressive DeFi feat and one which has allowed TMS Network (TMSN) to dominate clear from Conflux (CFX) and Zilliqa (ZIL).
In fact, the roaring success of TMS Network (TMSN)’s decentrally governed investment platform led to its initial stage of presale selling out in just two weeks! It’s already been a couple of weeks since the second wave of the TMS Network (TMSN) presale began, so don’t wait around as you’ll lose your opportunity before you know it!
One of the pitfalls of blockchain networking is how difficult it can be for one blockchain to connect with another. The Asian developers of Conflux (CFX) know this problem all too well – despite China being one of the world’s biggest crypto innovators, its blockchains are rarely interoperable with Western networks, something that Conflux (CFX) aims to change.
The Conflux (CFX) network is designed to be completely unbiased and flexible to operate with any blockchain around the world. Along with this unified approach to blockchain networks, Conflux (CFX) is likely to benefit greatly from the recent reelection of Xi Jinping, the president of the Republic of China who recently endorsed crypto providers such as Conflux (CFX)!
Behind every successful crypto project, there is a company such as Zilliqa (ZIL), a crypto provider that focuses on making DeFi more user-friendly. The Zilliqa (ZIL) network is designed to be highly scalable, low cost, environmentally sustainable, and developer friendly, ultimately stopping there from being anything preventing app developers to migrate to decentralized infrastructure.
Whilst Zilliqa (ZIL) has been smart to take such a developer-friendly approach to blockchain, it will struggle to build as much hype as TMS Network (TMSN) and Conflux (CFX) due to its B2B approach. With that being said, Zilliqa (ZIL) is considered a leader in crypto innovation right now and it has the features to back this up, so holding on to some Zilliqa (ZIL) in 2023 is likely a smart idea.
Overall, Conflux (CFX) and Zilliqa (ZIL) have been battling it out for months now, but since the reelection of crypto-enthusiast Xi Jinping, Conflux (CFX) is likely to storm ahead of Zilliqa (ZIL). However, Conflux’s (CFX) celebration is likely to be short-lived if the recent presale of TMS Network (TMSN) is anything to go by.
TMS Network (TSMN) sold out in just two weeks for its initial presale stage, and with its second stage ongoing for a couple of weeks, it’s only a matter of time until you’ll have to wait for the third wave. Get in early whilst TMS Network (TMSN) is still at bargain prices unless you want to miss out on yet another moonshot opportunity!
Disclaimer: The statements, views and opinions expressed in this article are solely those of the content provider and do not necessarily represent those of Crypto Reporter. Crypto Reporter is not responsible for the trustworthiness, quality, accuracy of any materials in this article. This article is provided for educational purposes only. Crypto Reporter is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in this article. Do your research and invest at your own risk.